Pfizer CFO: Responsible Spending is Path to Growth

While ramped up expenses hurt Pfizer's fourth-quarter earnings, company CFO Frank D'Amelio says responsible spending is helping build demand for its products in developed and emerging markets.


Reuters reports that Pfizer shares fell as much as 3.3% on Wednesday after fourth-quarter earnings failed to match analysts' forecasts and the company projected results this year and in 2012 below expectations -- losses that analysts blame on increased spending.


But D'Amelio believes the company's spending will pay off as it strives to expand deeper into existing markets and enter new ones. He says the the company reported very strong double-digit growth in Brazil, Russia, India and China.


"The most important thing is that we see opportunities to invest in the business," he told Reuters.

Suggested Articles

Some of you might have already been aware of the news that Questex—with the aim to focus on event business—will shut down permanently all media brands in Asia…

Some advice for transitioning into an advisory role

Global risks are intensifying but the collective will to tackle them appears to be lacking. Check out this report for areas of concern